Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Consensus Rating of “Buy” from Analysts
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) has been given an average recommendation of “Buy” by the six ratings firms that are currently covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) has been given an average recommendation of “Buy” by the six ratings firms that are currently covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The […]
